Teen suicides spiked in the month following the release of the Netflix series 13 Reasons Why, with the association restricted to boys. (Journal of the American Academy of Child & Adolescent Psychiatry)
Suicide attempts by poisoning are rising among teenagers in the U.S. — particularly among girls. (Journal of Pediatrics)
The FDA announced sleeping pills like zolpidem (Ambien) and eszopiclone (Lunesta) will now carry a black box warning about dangerous side effects, such as sleep driving. (MedPage Today)
Twenty genes were identified as being associated with bipolar disorder. “By discovering new genes associated with bipolar disorder and demonstrating their overlap with genes found in other psychiatric disorders, we bring ourselves closer to finding the true genetic underpinnings of the disease and improving patient outcomes,” said Eli Stahl, PhD, of the Icahn School of Medicine at Mount Sinai. (Nature Genetics)
Compared to non-pregnant women with depressive symptoms, pregnant women with depressive symptoms were less likely to report receiving any mental health treatment — 57% versus 49%, respectively. (Psychiatric Services)
Is LATE the newest form of dementia? (MedPage Today)
Childhood obesity may be an independent risk factor for depression and anxiety, according to new research presented at the European Congress on Obesity. “The next steps are to understand the implications of their co-occurrence and how to best intervene to promote good health,” said co-lead author Praveetha Patalay, PhD, of University College London.
People with major depression might have decreased striatal dopamine transporter expression reflecting lower dopamine signaling. (JAMA Psychiatry)
The FDA rejected Heron Therapeutics’ new drug application for their postoperative pain therapy HTX-011 — an extended-release formulation of local anesthetic bupivacaine.
The U.K. Health Secretary announced all opioids in the U.K. will now carry addiction warning labels. (BBC)